Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1986;8:1084-1088

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strazzullo, P.
Right arrow Articles by Mancini, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strazzullo, P.
Right arrow Articles by Mancini, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*High Blood Pressure

Hypertension, Vol 8, 1084-1088, Copyright © 1986 by American Heart Association


ARTICLES

Controlled trial of long-term oral calcium supplementation in essential hypertension

P Strazzullo, A Siani, S Gugliemi, A Di Carlo, F Galletti, M Cirillo and M Mancini

A randomized, double-blind, placebo-controlled crossover trial of oral calcium supplementation was carried out in 18 patients with uncomplicated essential hypertension. After 15 weeks of oral calcium supplementation, 1 g/day, of the patients' habitual diet, the only blood pressure change (compared with the results of placebo treatment) was in the average standing systolic blood pressure, which was significantly reduced (-8.6 mm Hg; p less than 0.01). The 24-hour urinary calcium excretion and the total serum calcium concentration increased significantly during calcium supplementation (p less than 0.05), indicating good compliance with the treatment. The individual blood pressure changes with high calcium intake were found to be inversely related to basal 24-hour urinary calcium excretion (r = - 0.69, p less than 0.001 for standing systolic pressure; r = -0.55, p less than 0.002 for standing diastolic pressure). This correlation was independent of age, basal blood pressure, serum calcium concentration, basal 24-hour urinary sodium excretion, and body weight changes during the trial. In particular, a subgroup of six patients, who had a basal 24-hour urinary calcium excretion higher than the mean + 2 SD of a reference healthy population previously described, showed a substantial average blood pressure fall at variance with the other patients in the study. These results do not support the usefulness of an oral calcium supplement in the majority of subjects with mild essential hypertension; however, they suggest that a group of patients with a previously reported abnormality of calcium metabolism may be responsive to this therapeutic measure.


This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
G. D. Miller, D. D. DiRienzo, M. E. Reusser, and D. A. McCarron
Benefits of Dairy Product Consumption on Blood Pressure in Humans: A Summary of the Biomedical Literature
J. Am. Coll. Nutr., April 1, 2000; 19(90002): 147S - 164.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. C. Bucher, R. J. Cook, G. H. Guyatt, J. D. Lang, D. J. Cook, R. Hatala, and D. L. Hunt
Effects of Dietary Calcium Supplementation on Blood Pressure: A Meta-analysis of Randomized Controlled Trials
JAMA, April 3, 1996; 275(13): 1016 - 1022.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension
Arch Intern Med, January 25, 1993; 153(2): 186 - 208.
[Abstract] [PDF]


Home page
JAMAHome page
The Trials of Hypertension Prevention Collaborativ, Members of the Trials of Hypertension Prevention C, Clinical Centers, P. K. Whelton, L. Appel, J. Charleston, A. T. Dalcin, C. Ewart, L. Fried, D. Kaidy, et al.
The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I
JAMA, March 4, 1992; 267(9): 1213 - 1220.
[Abstract] [PDF]


Home page
JAMAHome page
R. R. Williams, S. C. Hunt, P. N. Hopkins, B. M. Stults, L. L. Wu, S. J. Hasstedt, G. K. Barlow, S. H. Stephenson, J.-M. Lalouel, and H. Kuida
Familial Dyslipidemic Hypertension: Evidence From 58 Utah Families for a Syndrome Present in Approximately 12% of Patients With Essential Hypertension
JAMA, June 24, 1988; 259(24): 3579 - 3586.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. A. McCARRON and C. D. MORRIS
The Calcium Deficiency Hypothesis of Hypertension
Ann Intern Med, December 1, 1987; 107(6): 919 - 922.
[Abstract] [PDF]


Home page
JAMAHome page
F. P. Cappuccio and P. Strazzullo
Blood Pressure and Calcium Supplementation
JAMA, July 17, 1987; 258(3): 326 - 326.
[Abstract] [PDF]


Home page
JAMAHome page
R. M. Lyle, C. L. Melby, G. C. Hyner, J. W. Edmondson, J. Z. Miller, and M. H. Weinberger
Blood Pressure and Metabolic Effects of Calcium Supplementation in Normotensive White and Black Men
JAMA, April 3, 1987; 257(13): 1772 - 1776.
[Abstract] [PDF]